FHI

Federated Hermes is a high-quality, capital-light asset manager screening cheap: 11.0x trailing diluted EPS of $5.13 and 2.4x sales, against a 33.7% ROE, 28.5% operating margin and a clean balance sheet (liabilities/equity 0.81x, $583M cash vs. $348M long-term debt). FY2025 was a banner year — revenue +10.3% to $1.80B, net income +50.3% to $403M, EPS +58.8% (amplified by a 5.4% lower share count from $263M of buybacks). Management is clearly returning capital aggressively. On the surface this is a buy.

The hesitation is earnings durability, and the filing spells out why. Money market assets now drive 53% of revenue (up from 51% and 47% in the prior two years), with the MD&A attributing the gain to 'higher average money market assets' — i.e. this is a rate-cycle tailwind, not structural growth. The five-year history confirms the cyclicality: net income was lumpy ($270M→$239M→$299M→$268M) before 2025's jump to $403M, so paying 11x trailing earnings is closer to 11x a likely cyclical peak. Fee waivers were still a hefty $437.4M (mostly money-market related); a Fed easing cycle would compress MMF yields, lift waivers, and pressure the very revenue line that just expanded. Tellingly, operating cash flow fell 14.2% to $297M even as reported net income rose 50% — a divergence that argues against extrapolating the headline EPS.